Enkephalin-like character and analgesia.

[1]  S. Bajusz,et al.  Enkephalin analogs containing amino sulfonic acid and amino phosphonic acid residues at position 5 , 1980, FEBS letters.

[2]  H. Mazarguil,et al.  Structure-activity relationships of enkephalin analogs at opiate and enkephalin receptors: correlation with analgesia. , 1980, European journal of pharmacology.

[3]  H. Kosterlitz,et al.  EFFECTS OF CHANGES IN THE STRUCTURE OF ENKEPHALINS AND OF NARCOTIC ANALGESIC DRUGS ON THEIR INTERACTIONS WITH μ‐ AND δ‐RECEPTORS , 1980 .

[4]  P. Lehmann.  STEREOSELECTIVITY AND AFFINITY OF OPIOID RECEPTORS FOR DIASTEREOMERIC ENKEPHALINS , 1980 .

[5]  C. Pert,et al.  TYPE 1 AND TYPE 2 OPIATE RECEPTORS: A SUBCLASSIFICATION SCHEME BASED UPON GTP'S DIFFERENTIAL EFFECTS ON BINDING , 1980 .

[6]  G. Metcalfe,et al.  STRUCTURE-FUNCTION STUDIES IN PEPTIDES RELATED TO THE β-LPH61-64 SEQUENCE , 1980 .

[7]  H. Kosterlitz.  Opioid peptides and their receptors. , 1980, Progress in biochemical pharmacology.

[8]  S. Bajusz,et al.  Tetrapeptide-amide analogues of enkephalin: the role of C-terminus in determining the character of opioid activity. , 1979, Biochemical and biophysical research communications.

[9]  R. Olson,et al.  CNS effects of peripherally administered brain peptides. , 1979, Life sciences.

[10]  P. Cuatrecasas,et al.  Multiple opiate receptors: different regional distribution in the brain and differential binding of opiates and opioid peptides. , 1979, Molecular pharmacology.

[11]  I. Kitchen,et al.  DIFFERENT EFFECTS OF CURRENT STRENGTH ON INHIBITORY RESPONSES OF THE MOUSE VAS DEFERENS TO METHIONINE‐ AND LEUCINE‐ENKEPHALIN , 1979, British journal of pharmacology.

[12]  R. Schulz,et al.  Selective receptors for β-endorphin on the rat vas deferens , 1979 .

[13]  L. Gráf,et al.  Kinetic studies in isolated organs: tools to design analgesic peptides and to analyze their receptor effects. , 1979, Pharmacology.

[14]  S. Bajusz,et al.  In vivo antagonism by naloxone of morphine, beta-endorphin and a synthetic enkephalin analog. , 1978, The Journal of pharmacology and experimental therapeutics.

[15]  D. Regoli,et al.  RAT VAS DEFERENS: A SPECIFIC BIOASSAY FOR ENDOGENOUS OPIOID PEPTIDES , 1978, British journal of pharmacology.

[16]  L. Gráf,et al.  Is there correlation between analgesic potency and biodegradation of enkephalin analogs? , 1978, Biochemical and biophysical research communications.

[17]  L. Stein,et al.  Potent analgesic activity of the enkephalin-like tetrapeptide H-Tyr-D-Ala-Gly-Phe-NH2. , 1978, Life sciences.

[18]  L. Stein,et al.  Enhanced analgesic activity of D-Ala2 enkephalinamides following D-isomer substitutions at position five. , 1978, Life sciences.

[19]  J. Shaw,et al.  In vitro profile of some opioid pentapeptide analogues. , 1978, European journal of pharmacology.

[20]  H. Takagi,et al.  Analgesia by enkephalins injected into the nucleus reticularis gigantocellularis of rat medulla oblongata. , 1978, European journal of pharmacology.

[21]  A. Sassi,et al.  Opiate receptors: different ligand affinity in various brain regions. , 1978, Advances in biochemical psychopharmacology.

[22]  C. Beddell,et al.  A CONFORMATIONAL ANALYSIS FOR LEUCINE‐ENKEPHALIN USING ACTIVITY AND BINDING DATA OF SYNTHETIC ANALOGUES , 1977, British journal of pharmacology.

[23]  S. Bajusz,et al.  Differentiation between opioid peptides by naltrexone. , 1977, European journal of pharmacology.

[24]  C. Beddell,et al.  Structural requirements for opioid activity of analogues of the enkephalins , 1977, Proceedings of the Royal Society of London. Series B. Biological Sciences.

[25]  F. Cardinaux,et al.  A synthetic enkephalin analogue with prolonged parenteral and oral analgesic activity , 1977, Nature.

[26]  John Hughes,et al.  Endogenous opioid peptides: multiple agonists and receptors , 1977, Nature.

[27]  L. Gráf,et al.  A superactive antinociceptive pentapeptide, (D‐Met2,Pro5)‐enkephalinamide , 1977, FEBS letters.

[28]  L. Gráf,et al.  Differential behaviour of LPH‐(61–91)‐peptide in different model systems: Comparison of the opioid activities of LPH‐(61–91)‐peptide and its fragments , 1977, FEBS letters.

[29]  C. Pinsky,et al.  Intraventricular Met5-enkephalin causes unexpected lowering of pain threshold and narcotic withdrawal signs in rats , 1976, Nature.

[30]  A. Pert,et al.  (D-Ala2)-Met-enkephalinamide: a potent, long-lasting synthetic pentapeptide analgesic. , 1976, Science.

[31]  J. Knoll.  Neuronal peptide (enkephalin) receptors in the ear artery of the rabbit. , 1976, European journal of pharmacology.

[32]  B. Morgan,et al.  Mode of deactivation of the enkephalins by rat and human plasma and rat brain homogenates , 1976, Nature.

[33]  A. Pert,et al.  Opiate receptor affinities and behavioral effects of enkephalin: structure-activity relationship of ten synthetic peptide analogues. , 1976, Life sciences.

[34]  L. Gráf,et al.  Enkephalin analogs with enhanced opiate activity. , 1976, Acta biochimica et biophysica; Academiae Scientiarum Hungaricae.

[35]  F. Leslie,et al.  EFFECT OF MORPHINE ON ADRENERGIC TRANSMISSION IN THE MOUSE VAS DEFERENS. ASSESSMENT OF AGONIST AND ANTAGONIST POTENCIES OF NARCOTIC ANALGESICS , 1975, British journal of pharmacology.

[36]  Amatuni Vn,et al.  [Chemical structure-biological activity relationship]. , 1974 .

[37]  W. Paton,et al.  The inhibitory action of noradrenaline and adrenaline on acetylcholine output by guinea‐pig ileum longitudinal muscle strip , 1969, British journal of pharmacology.

[38]  W. Paton,et al.  A theory of drug action based on the rate of drug-receptor combination , 1961, Proceedings of the Royal Society of London. Series B. Biological Sciences.

[39]  F. Wilcoxon,et al.  A simplified method of evaluating dose-effect experiments. , 1948, The Journal of pharmacology and experimental therapeutics.

[40]  Fred E. D'Amour,et al.  A METHOD FOR DETERMINING LOSS OF PAIN SENSATION , 1941 .